Skip to main content
Beat Cancer EU Website Logo
Prepreke za dobivanje naknadne skrbi među djetinjstvima koja su preživjela rak
Dugotrajna naknadna njegaAllArticle

Prepreke za dobivanje naknadne skrbi među djetinjstvima koja su preživjela rak

Ovaj članak identificira prepreke s kojima se osobe koje su preživjele rak u djetinjstvu mogu suočiti kada je u pitanju dugotrajna skrb.

Godina:2023

Barriers to Receiving Follow-up Care Among Childhood Cancer SurvivorsLittle is known on why adherence to follow-up care in childhood cancer survivors (CCS) is lacking. This study characterized barriers to adherence to follow-up care among CCS, identified sociodemographic correlates of barriers, and examined whether barriers to follow-up care relate to health-related quality of life. Adult CCS (N=84) were anonymously surveyed via REDCap using the Barriers to Care Questionnaire (BCQ) and the Quality of Life Scale-Cancer Survivor (QOL-CS).

Both descriptive and correlation analyses were conducted. The median BCQ total score was 88.5 (interquartile ranges: 78.4 to 95.7), with the greatest barriers reported in the Skills (eg, ease of navigating the healthcare system) and Pragmatism subscales (eg, cost). There was a statistically significant correlation between the BCQ total score and the QOL-CS total score (rs=0.47, P <0.0001) and the physical, psychological, and social QOL-CS subscales (all P ‘s<0.05).

The results found that barriers to follow-up care for CCS are mostly related to cost and appointment logistics, and that more barriers to care is associated with lower health-related quality of life among CCS. Identifying barriers to follow-up care is the first step in improving adherence, which would allow for earlier detection of late effects of cancer therapy and thereby result in reductions in morbidity and mortality.

Rasprava i pitanja

Napomena: Komentari služe samo za raspravu i pojašnjenje. Za medicinske savjete, obratite se zdravstvenom djelatniku.

Ostavite komentar

Minimalno 10 znakova, maksimalno 2000 znakova

Još nema komentara

Budite prvi koji će podijeliti svoje mišljenje!